alexa Primary biliary cirrhosis | Russia| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences
  • International Conference
    Exploring the innovation in Emergency & Acute Care Medicine
    August 22-23, 2018 Tokyo, Japan
  • 14th International Conference
    Clinical Gastroenterology and Hepatology
    Theme: Knowing the unknown and finer facets of Gastroenterology
    August 29-30, 2018 Toronto, Canada
  • World Conference
    New Technologies and Methodologies in Neurology ad Neuromuscular Disorders
    September 13-14, 2018 Frankfurt, Germany
  • 3rd International Conference on
    Internal Medicine and Hospital Medicine
    October 23-24, 2018 Toronto, Canada

Relevant Topics

Primary Biliary Cirrhosis

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Primary biliary cirrhosis

    Disease pathophysiology: 

    Primary biliary cirrhosis is inflammation with progressive scarring of the bile ducts in the liver. Eventually, the ducts are blocked, the liver becomes scarred, and cirrhosis and liver failure develop. Primary biliary cirrhosis probably results from an autoimmune reaction. This disorder commonly causes itchiness, fatigue, dry mouth and eyes, and jaundice, but some people have no symptoms.

  • Primary biliary cirrhosis

     Disease statistics: 

    The prevalence of PBC has been estimated as 12.9 per 100,000 population with up to 90% of cases occurring in women. Diagnosis is usually between about 45 and 55 years old.The prevalence appears to have been rising since 1980. This may be in part due to increased survival but is probably also due to better awareness of the disease

  • Primary biliary cirrhosis

     Disease treatment:

    The goals of treatment are to slow the progression rate of the disease and to alleviate the symptoms (eg,pruritus, osteoporosis, sicca syndrome). Liver transplantation appears to be the only life-saving procedure. Immunosuppressive agents inhibit immune reactions that mediate the progression of the disease. Increased activity is recommended, especially in postmenopausal women, to prevent osteoporosis.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings